Russian Ophthalmological Journal最新文献

筛选
英文 中文
The effect of silicone oil on the anatomical and functional parameters of the retina during surgery of regmatogenic retinal detachment 再吸收性视网膜脱离手术中硅油对视网膜解剖和功能参数的影响
Russian Ophthalmological Journal Pub Date : 2024-07-02 DOI: 10.21516/2072-0076-2024-17-2-142-147
V. Neroev, O. V. Zaytseva, A. I. Ushakov
{"title":"The effect of silicone oil on the anatomical and functional parameters of the retina during surgery of regmatogenic retinal detachment","authors":"V. Neroev, O. V. Zaytseva, A. I. Ushakov","doi":"10.21516/2072-0076-2024-17-2-142-147","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-142-147","url":null,"abstract":"Vitrectomy followed by endotamponade of the vitreal cavity with silicone oil (SO) is one of the main techniques of treating severe forms of regmatogenic retinal detachment (RRD). Endotamponade with SO, having numerous advantages and a huge potential, carries the risk of a number of complications arising at various times of application. The literature review analyzes the published data on the effect of tamponade SO on the retina and the function of central vision in RRD surgery: visual acuity, indicators of light and color sensitivity, data of electrophysiological test results. Possible causes of deteriorated central vision functions directly or indirectly related to tamponade with SO are discussed: changes in the thickness and structure of the retina or its individual layers as shown by optical coherence tomography (OCT) data, microcirculation disorders according to OCT angiography, fluorescein angiography, Doppler laser scanning, as well as pathohistological findings related to SO migration into the fundus of eye tissues.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"16 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141684933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is microbiota a factor in the mechanism of glaucoma development? 微生物群是青光眼发病机制中的一个因素吗?
Russian Ophthalmological Journal Pub Date : 2024-07-02 DOI: 10.21516/2072-0076-2024-17-2-148-153
O. I. Orenburkina, A. Babushkin, S. M. Shamsutdinov
{"title":"Is microbiota a factor in the mechanism of glaucoma development?","authors":"O. I. Orenburkina, A. Babushkin, S. M. Shamsutdinov","doi":"10.21516/2072-0076-2024-17-2-148-153","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-148-153","url":null,"abstract":"Nowadays, glaucoma is viewed as a multifactorial neurodegenerative condition that involves many factors affecting different cell types in a human body. As is known, increased intraocular pressure (IOP) is not the only threatening factor of ganglion cell apoptosis and glaucomatous optic neuropathy development; IOP can be associated with other factors, such as vascular, metabolic, neurotrophic, immune, inflammatory, etc. However, the treatment of glaucoma remains largely symptomatic, aimed almost exclusively at reducing IOP. Microbiotic dysbiosis is a newly developing research direction of the glaucomatous progress, showing that this mechanism may turn out to be an important factor of glaucoma development. There are reasons to believe that treatment strategies aimed at microbiota damage correction may contribute to a better efficiency of glaucoma management. ","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"23 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141684767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endothelial keratoplasty in integrity-damaged iridolenticular diaphragm 完整性受损的虹膜横隔内皮角膜移植术
Russian Ophthalmological Journal Pub Date : 2024-07-02 DOI: 10.21516/2072-0076-2024-17-2-160-165
A. V. Tereshchenko, S. K. Demyanchenko, Y.D. Erina, A. Pashtaev, K. I. Katmakov, Y. M. Trifanenkova, A. Gelyastanov, A. A. Lugovaya
{"title":"Endothelial keratoplasty in integrity-damaged iridolenticular diaphragm","authors":"A. V. Tereshchenko, S. K. Demyanchenko, Y.D. Erina, A. Pashtaev, K. I. Katmakov, Y. M. Trifanenkova, A. Gelyastanov, A. A. Lugovaya","doi":"10.21516/2072-0076-2024-17-2-160-165","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-160-165","url":null,"abstract":"The review presents methods for performing endothelial keratoplasty (EK) in patients with endothelial corneal dysfunction, combined with discontinuities of the iridolenticular diaphragm as reflected in the PubMed, Scopus and eLibrary reference databases for the period ending in 2022. EK performed according to a variety of techniques allows achieving good clinical and functional results and reducing the risk of complications at different stages of treatment of patients with endothelial insufficiency. Another important advantage of EK as compared to penetrating keratoplasty is the fact that it can be repeated multiple times, which is relevant for patients with severe combined pathologies. Considering the plethora of modifications of posterior lamellar keratoplasty and transplantation of the Descemet's membrane and endothelium for cases with combined damages of the integrity of the iridolenticular diaphragm, the number of affected patients may be even more numerous than presented in the publications reviewed. The variety of literature data shows that the search for a universal technique of EK to be performed on patients with various disorders of the iridolenticular diaphragm is likely to continue.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"25 42","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141684528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment 用于治疗青光眼的本地降压药物开发的当前趋势和前景
Russian Ophthalmological Journal Pub Date : 2024-07-02 DOI: 10.21516/2072-0076-2024-17-2-154-159
S. Petrov, O. M. Fillipova, T. N. Malishevskaya, O. I. Markelova
{"title":"Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment","authors":"S. Petrov, O. M. Fillipova, T. N. Malishevskaya, O. I. Markelova","doi":"10.21516/2072-0076-2024-17-2-154-159","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-154-159","url":null,"abstract":"Glaucoma is one of the world’s primary causes of blindness. Russia is following the global increasing trends of glaucoma and its leading position among ophthalmic pathologies that cause irreversible loss of vision. Elevated intraocular pressure (IOP) is the only modifiable risk factor of glaucoma, so treatment strategies specifically focus on reducing IOP by suppressing the production of intraocular fluid and boosting its outflow. The current review presents new medications aimed at glaucoma and high IOP control that have recently appeared at the international market as well as the drugs under the different stages of development, from experimental to clinical studies. These include both the developments of agents belonging to the existing classes and of entirely new drugs intended to control IOP. In an attempt to reduce the side effects of locally administered drugs and prolong their action, in parallel with the development of new drugs, there is also evidence of alternative methods of drug delivery: intraocular implants, injectable forms and obturators, combinations of polymers and colloidal systems.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"13 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141685987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scleral collagen crosslinking as a promising direction of sclera-strengthening treatment of progressive myopia 巩膜胶原交联作为硬化强化治疗渐进性近视的一个有前途的方向
Russian Ophthalmological Journal Pub Date : 2024-07-02 DOI: 10.21516/2072-0076-2024-17-2-128-134
E. Iomdina, E. Tarutta, G. A. Markosyan, V. N. Papyan, S. Milash
{"title":"Scleral collagen crosslinking as a promising direction of sclera-strengthening treatment of progressive myopia","authors":"E. Iomdina, E. Tarutta, G. A. Markosyan, V. N. Papyan, S. Milash","doi":"10.21516/2072-0076-2024-17-2-128-134","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-128-134","url":null,"abstract":"The review presents recent research works on new technologies of scleral collagen crosslinking, a promising approach to sclerastrengthening treatment of progressive myopia. We assess the advantages and limitations of a number of experimental techniques of photochemical and medicinal crosslinking of the sclera, as well as donor tissue crosslinking aimed at optimizing the plastic material for sclera-strengthening surgery. Successful experiments and effective first clinical implementation results of the approach can be viewed as the basis for its further improvement and wider introduction of the technology into ophthalmological practice.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"6 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141684685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in ophthalmology: the present and the future 眼科人工智能:现状与未来
Russian Ophthalmological Journal Pub Date : 2024-07-02 DOI: 10.21516/2072-0076-2024-17-2-135-141
V. Neroev, O. V. Zaytseva, S. Petrov, A. A. Bragin
{"title":"Artificial intelligence in ophthalmology: the present and the future","authors":"V. Neroev, O. V. Zaytseva, S. Petrov, A. A. Bragin","doi":"10.21516/2072-0076-2024-17-2-135-141","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-135-141","url":null,"abstract":"The medical industry is undergoing an active digital transformation, including the creation of electronic databases, cloud security systems, mobile health monitoring devices, and telemedicine tools. Artificial intelligence (AI), one of the most important technological achievements of the last decade, is gradually gaining momentum in various areas of practical medicine. The cutting edge of AI, neural networks, offers promising approaches to the improvement of clinical examination quality. The review presents data of studies focusing on the use of AI tools in the diagnosis of the most common ophthalmic diseases: diabetic retinopathy, macular degeneration, retinopathy of prematurity, glaucoma, cataracts, and ophthalmic oncology. We discuss both the advantages of neural networks in the diagnosis and monitoring of eye diseases, and outline the difficulties of their implementation, including ethical and legal conflicts.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"354 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141686837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In memoriam of Abdul-Hamid Davudovich Aliyev 悼念阿卜杜勒-哈米德-达武多维奇-阿利耶夫
Russian Ophthalmological Journal Pub Date : 2024-07-02 DOI: 10.21516/2072-0076-2024-17-2-166
A. Editorial
{"title":"In memoriam of Abdul-Hamid Davudovich Aliyev","authors":"A. Editorial","doi":"10.21516/2072-0076-2024-17-2-166","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-166","url":null,"abstract":"<jats:p>.</jats:p>","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"7 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141685759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modelling of the early stage of retinal neurodegeneration via a topical injection of dopaminergic neurotoxin 通过局部注射多巴胺能神经毒素模拟视网膜神经变性的早期阶段
Russian Ophthalmological Journal Pub Date : 2024-07-01 DOI: 10.21516/2072-0076-2024-17-2-55-61
T. Pavlenko, N. Chesnokova, O. Beznos, A. V. Grigoryev, T. D. Okhotsimskaya, N. N. Shikareva
{"title":"Modelling of the early stage of retinal neurodegeneration via a topical injection of dopaminergic neurotoxin","authors":"T. Pavlenko, N. Chesnokova, O. Beznos, A. V. Grigoryev, T. D. Okhotsimskaya, N. N. Shikareva","doi":"10.21516/2072-0076-2024-17-2-55-61","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-55-61","url":null,"abstract":"Purpose: to develop a model of the early stage of retinal neurodegeneration via an intravitreal injection of the dopaminergic neurotoxin. Material and methods. The experiment was carried out on 20 Chinchilla rabbits. The experimental groups received intravitreal injection of 0.1 ml of 6-hydroxydopamine (6-OHDA) in NaCl 0.9 % with 0.5 % ascorbate, containing 0.25 or 0.5 mg 6-OHDA. The control group received injections of 0.1 ml of NaCl-ascorbate solution without neurotoxin. On the 7th and the 14th days after the injection, intraocular pressure (IOP), pupillary light reaction and ocular blood flow were estimated and the fundus was examined. On the 7th day after an injection of 0.25 mg 6-OHDA, we used ELISA to measure dopamine concentration in retinal homogenates, while on the 14th day after an injection of 0.5 mg 6-OHDA, the concentrations of dopamine, norepinephrine, TNF-a and endothelin-1 were measured by the same method. Results. On the 7th day after a 0,25 mg injection of neurotoxine, we revealed a decrease of dopamine in the retina (0.043 ± 0.130 pg/mg protein compared with 0.10 ± 0,03 pg/mg protein in the controls, р < 0.01). On the 14th day, dopamine and norepinephrine levels showed a fourfold increase (р < 0.05). An injection of 0.5 mg of 6-OHDA caused a threefold increase of dopamine (р < 0.05) and a fivefold increase of norepinephrine (р < 0.01) concentration in comparison with the controls. On the 14th day, endotheline-1 level was 65 % higher than in the controls after a 0.25 mg 6-OHDA injection (р < 0.01) and 45 % higher after a 0,5 mg injection (р<0.05). At the same time, TNF-α levels increased by 43 % (р < 0.05) and 20 % (р < 0.05) respectively. We also revealed a dose-dependent change of IOP, a disturbance of pupillary light reaction and decreased ocular blood flow after an injection of neurotoxin. Conclusion. A single intravitreal injection of dopaminergic neurotoxin 6-OHDA in the amount of 0.25 or 0.5 mg per eye leads to a neuroinflammation and vascular disorders, which are the main pathogenetic pathways of neurodegeneration. To model its early phase, the 0.25 mg dose is preferable as it causes less dramatic functional disorders. The latter model can be useful for the investigation of retinal neurodegeneration pathogenesis, the search for early diagnostic and prognostic markers thereof and the estimation of therapy effectiveness.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"7 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141715985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms 作为 COVID-19 冠状病毒感染并发症的粘液瘤病:眼部症状
Russian Ophthalmological Journal Pub Date : 2024-07-01 DOI: 10.21516/2072-0076-2024-17-2-116-120
A. Babushkin, L. I. Gilemzianova, I. P. Ponomarev
{"title":"Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms","authors":"A. Babushkin, L. I. Gilemzianova, I. P. Ponomarev","doi":"10.21516/2072-0076-2024-17-2-116-120","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-116-120","url":null,"abstract":"COVID-19 causes an immunosuppressive condition and increases the risk of secondary infections, including fungal diseases such as mucormycosis (MM), so doctors should be aware of the possibility of MM development in COVID-19 patients. Since no specific complaints or clinical symptoms exist and the disease is rare, especially in developed countries with a moderate climate, it is often impossible to diagnose MM at the initial examination. Therefore, the detection of the pathogen (mycelium zygomycetes) plays a key role in the diagnosis. Over 70 % of MM patients experience eye damages. According to the literature, the most common manifestations thereof are blepharoptosis, ophthalmoplegia, exophthalmos, injection and conjunctival chemosis. Quite often, the patients have eye pains, orbital cellulitis or phlegmon of the orbit, accompanied by a decrease in vision. For the effective treatment of this severe infectious COVID-19 complication, which takes the form of deep and aggressive mycosis, an interdisciplinary approach is necessary. The complex treatment should make use of antimycotic agents and symptomatic therapy, and, essentially, surgical rehabilitation of infection foci by removing the affected necrotic tissues. The prognosis is always very serious.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"88 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141714282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and treatment of optic neuritis as a manifestation of persistent herpesvirus infection: a clinical case 视神经炎是疱疹病毒持续感染的一种表现形式的诊断和治疗:一个临床病例
Russian Ophthalmological Journal Pub Date : 2024-07-01 DOI: 10.21516/2072-0076-2024-17-2-93-98
J. Issakhanova, A. K. Duisenova, A. Z. Kurmasheva, D. E. Zhumabek
{"title":"Diagnosis and treatment of optic neuritis as a manifestation of persistent herpesvirus infection: a clinical case","authors":"J. Issakhanova, A. K. Duisenova, A. Z. Kurmasheva, D. E. Zhumabek","doi":"10.21516/2072-0076-2024-17-2-93-98","DOIUrl":"https://doi.org/10.21516/2072-0076-2024-17-2-93-98","url":null,"abstract":"A clinical case of bilateral descending optic neuritis in a 63-year-old patient is presented. The patient, whose age is beyond the normal limit for this pathology, was previously treated for neuritis of the right eye, which had no effect and led to a complete atrophy of the optic nerve (ON). A timely correct diagnostics of the left eye, which revealed structural disorders of the optic nerve accompanied by inflammatory viral changes of brain tissue, was a key factor in choosing an adequate treatment, which helped retain visual functions. The clinical observation illustrates the polyetiological nature of inflammation of the ON, the viral agent playing a leading role. Importantly, ophthalmic manifestations of the herpesvirus infection may remain the only sign of this pathology for a long time, so the ophthalmologist must always be on the alert regarding the viral genesis of the disease.","PeriodicalId":21436,"journal":{"name":"Russian Ophthalmological Journal","volume":"2002 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141707541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信